Position in NBIX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,234,218
+$274,361 QoQ
Shares Held
7,323
+0.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#368
of 768 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HB Wealth Management, LLC holds $9,010,122 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
38,820 | $2,789,605 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,331 | $1,263,005 | |
| 3 | HLN |
Haleon plc
|
133,227 | $1,243,007 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
7,323 | $1,234,218 | |
| 5 | VTRS |
Viatris Inc
|
58,985 | $936,681 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,693 | $294,518 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
19,136 | $277,280 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
11,108 | $273,367 |
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,234,218 | 7,323 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $959,857 | 7,286 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $683,478 | 4,819 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $501,156 | 3,570 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $277,020 | 2,204 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $257,587 | 2,329 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $373,327 | 2,735 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||